Linked Life Data

11966241

Source:http://linkedlifedata.com/resource/pubmed/id/11966241

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-4-22
pubmed:abstractText
Morphologic complications continue to be observed in patients receiving HAART. Body habitus changes include fat accumulation, lipoatrophy, and HIV-associated wasting. Anthropometry, dual-energy x-ray absorptiometry, and imaging methods (CT, MRI) are most useful for detecting fat redistribution syndromes, while bioelectric impedance analysis is useful for determining and monitoring wasting. Various clinical interventions, including diet and exercise, switching antiretroviral agents, the use of lipid-lowering and insulin-sensitizing agents, recombinant human growth hormone therapy, and plastic surgery, are under investigation for the treatment of morphologic changes. Prospective, controlled clinical trials are needed to determine the long-term efficacy of these approaches.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
X
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1053-0894
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
114-9, 124-5
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Identifying and managing morphologic complications of HIV and HAART.
pubmed:affiliation
University of California, Los Angeles, School of Medicine, USA.
pubmed:publicationType
Journal Article